title: Prebiotic Oligosaccharides: Comparative Evaluation Using In Vitro Cultures of Infants' Fecal Microbiomes.
abstract: The objective of this study was to systematically assess the bifidogenic effect of three commonly used prebiotic products using in vitro cultures of infant fecal samples. Fresh stool samples collected from six term infants, each exclusively fed human milk (n = 3) or infant formula (n = 3), at 28 days of age were used as inocula. The following prebiotic products were added at concentrations applicable to infant formula: Vivinal GOS 15 (containing 28.5% galacto-oligosaccharide [GOS]) at 7.2 g/liter, Beneo HP (99.5% long-chain inulin [IN]) at 0.8 g/liter, Beneo Synergy 1 (enriched oligofructose and inulin [OF-IN]) at 4 g/liter, and a combination of Vivinal GOS 15 (7.2 g/liter) and Beneo HP (0.8 g/liter) (GOS-IN). The growth of total bacteria, Bifidobacterium, Bacteroides, Bifidobacterium longum, and Escherichia coli was quantified using specific quantitative PCR (qPCR). Bifidobacterium was also enumerated on selective Beerens agar plates, with representative colonies identified by sequencing of their 16S rRNA genes. Volatile fatty acids (VFA) and pH in the cultures were also determined. Irrespective of the feeding methods, the GOS product, either alone or in combination with Beneo HP, resulted in substantially higher growth of total bifidobacteria, and much of this growth was attributed to growth of B. longum. Beneo Synergy 1 also increased the abundance of total bifidobacteria and B. longum. Corresponding to the increases in these two bacterial groups, acetic acid concentrations were higher, while there was a trend of lower E. coli levels and pH. The lower pH and higher acetic acid concentration might be directly responsible for the lower E. coli population. At the concentrations studied, the GOS product was more bifidogenic and potent in inhibiting E. coli than the other products tested. These results suggest that supplementation of infant formula with GOS may increase intestinal bifidobacteria and benefit infant health.
authors.affiliation: Department of Animal Sciences, The Ohio State University, Columbus, Ohio, USA.
authors.forename: J
authors.initials: J
authors.lastname: Stiverson
authors.affiliation: Department of Animal Sciences, The Ohio State University, Columbus, Ohio, USA Abbott Nutrition, Columbus, Ohio, USA.
authors.forename: T
authors.initials: T
authors.lastname: Williams
authors.affiliation: Department of Animal Sciences, The Ohio State University, Columbus, Ohio, USA.
authors.forename: J
authors.initials: J
authors.lastname: Chen
authors.affiliation: Department of Animal Sciences, The Ohio State University, Columbus, Ohio, USA.
authors.forename: S
authors.initials: S
authors.lastname: Adams
authors.affiliation: Abbott Nutrition, Columbus, Ohio, USA.
authors.forename: D
authors.initials: D
authors.lastname: Hustead
authors.affiliation: Abbott Nutrition, Columbus, Ohio, USA.
authors.forename: P
authors.initials: P
authors.lastname: Price
authors.affiliation: Institute of Clinical Research, Mayfield Heights, Ohio, USA.
authors.forename: J
authors.initials: J
authors.lastname: Guerrieri
authors.affiliation: Institute of Clinical Research, Mayfield Heights, Ohio, USA.
authors.forename: J
authors.initials: J
authors.lastname: Deacon
authors.affiliation: Department of Animal Sciences, The Ohio State University, Columbus, Ohio, USA yu.226@osu.edu.
authors.forename: Z
authors.identifier: http://orcid.org/0000-0002-6165-8522
authors.initials: Z
authors.lastname: Yu
mesh_terms: D058491:Bacterial Load; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D004275:DNA, Ribosomal / Q000737:chemistry / Q000235:genetics; D005227:Fatty Acids / Q000032:analysis; D005243:Feces / Q000382:microbiology*; D000069196:Gastrointestinal Microbiome / Q000187:drug effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007223:Infant; D064307:Microbiota / Q000187:drug effects*; D009844:Oligosaccharides / Q000378:metabolism*; D056692:Prebiotics / Q000008:administration & dosage*; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D017422:Sequence Analysis, DNA
chemical_list: D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D005227:Fatty Acids; D009844:Oligosaccharides; D056692:Prebiotics; D012336:RNA, Ribosomal, 16S